文献速递医学人工智能与信息学基础与转化研究

深度学习在组织病理学中的应用:通往临床之路

Deep learning in histopathology: the path to the clinic.
PubMed 文献 · Nat Med · 2021-05-14

该综述指出,深度学习算法在肿瘤检测和分级等组织病理学任务上表现与训练有素的病理学家相近,但真正进入临床实施的算法极少,文章系统梳理了该领域现状及实现临床价值前仍需解决的挑战。

要点

  • 深度学习在肿瘤检测与分级等任务上可达到与病理学家相近的表现。
  • 已报道的算法中仅极少数进入临床实施,希望与炒作并存。
  • 实现临床价值前仍需解决多项挑战,综述对此进行了描述。

核心结论

  • 深度学习在组织病理学中潜力大且部分任务表现与病理学家相近,但临床落地算法极少。

研究设计与样本

  • 综述类文章,检索范围与纳入文献数量原文未报告。

主要发现

  • 深度学习算法在肿瘤检测和分级等任务上表现与训练有素的病理学家相近。
  • 尽管结果令人期待,极少数算法达到临床实施。

局限性

  • 综述指出,人工智能在组织病理学实现临床价值前仍有挑战需要解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Machine learning techniques have great potential to improve medical diagnostics, offering ways to improve accuracy, reproducibility and speed, and to ease workloads for clinicians. In the field of histopathology, deep learning algorithms have been developed that perform similarly to trained pathologists for tasks such as tumor detection and grading. However, despite these promising results, very few algorithms have reached clinical implementation, challenging the balance between hope and hype for these new techniques. This Review provides an overview of the current state of the field, as well as describing the challenges that still need to be addressed before artificial intelligence in histopathology can achieve clinical value.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. van der Laak J, Litjens G, Ciompi F, et al. Deep learning in histopathology: the path to the clinic. Nat Med. 2021. PMID: 33990804. doi:10.1038/s41591-021-01343-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。